SLC25A1 and cancer: Pharmacologic Inhibition of SLC25A1 Sensitizes Cancer Cells to the Cytotoxic Action of Ionizing Radiation (IR) and Overcomes Increased Radioresistance Induced by Chronic Cycling Severe Hypoxia